GlassScriptPhysician profile
Robert H Mead
NPI 1598721698
$183,752.62
in general payments reported to CMS, 2019-2025
23 companies · $6,424 in 2025
The $6,424 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $33K · 2021: $23K · 2022: $27K · 2023: $30K · 2024: $36K · 2025: $6,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $67K · Food and Beverage: $2,507 · Travel and Lodging: $2,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,238.00 |
| Food and Beverage | $2,507.19 |
| Travel and Lodging | $2,368.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $146,681.10 | 2019-2024 | Zio Xt Patch |
| Medtronic, INC. | $20,086.47 | 2021-2025 | Micra |
| Medtronic Vascular, INC. | $11,027.70 | 2019-2020 | |
| Medical Device Business Services, INC. | $1,131.46 | 2019 | |
| Atricure, INC. | $838.05 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Biosense Webster, INC. | $626.28 | 2019-2025 | Carto 3 |
| Abbott Laboratories | $545.49 | 2019-2023 | Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $488.97 | 2019-2024 | Rhythmia Mapping System |
| Janssen Pharmaceuticals, INC | $423.49 | 2019-2020 | |
| Stryker Corporation | $281.04 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.59 | 2019-2020 | |
| Ablacon, INC. | $241.23 | 2023 | |
| Medicure Pharma INC. | $227.81 | 2020 | |
| Pfizer INC. | $196.84 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $184.63 | 2024 | Optimizer |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $121.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $83.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $67.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $65.79 | 2019-2020 | |
| Novo Nordisk INC | $43.55 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $33.11 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.